Basilea Pharmaceutica AG
SIX:BSLN

Watchlist Manager
Basilea Pharmaceutica AG Logo
Basilea Pharmaceutica AG
SIX:BSLN
Watchlist
Price: 43.65 CHF -1.47% Market Closed
Updated: May 20, 2024
BSLN
/
Income Statement
/
Income from Continuing Operations

Basilea Pharmaceutica AG
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Basilea Pharmaceutica AG
Income from Continuing Operations Peer Comparison

Comparables:
ADCT
ACIU
CRSP
IDIA
KURN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Basilea Pharmaceutica AG
SIX:BSLN
Income from Continuing Operations
CHf10.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Income from Continuing Operations
-$234.5m
CAGR 3-Years
2%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Income from Continuing Operations
-CHf54.2m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Income from Continuing Operations
-$217.1m
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Income from Continuing Operations
-CHf827.9m
CAGR 3-Years
-19%
CAGR 5-Years
-122%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Income from Continuing Operations
-CHf13.7m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

See Also

What is Basilea Pharmaceutica AG's Income from Continuing Operations?
Income from Continuing Operations
10.5m CHF

Based on the financial report for Dec 31, 2023, Basilea Pharmaceutica AG's Income from Continuing Operations amounts to 10.5m CHF.

What is Basilea Pharmaceutica AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-14%

Over the last year, the Income from Continuing Operations growth was -14%.

ALPHA SPREAD
Join more than 138,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.